Ann: Appendix 2A, page-21

The answer I believe is in last years annual report, Maria gets paid about $150K for her consulting service to Lyramid taken as equity.

Thats a small price for the returns touted????

1. Cellmid is likely to retain patent and other intellectual property ownership
• A license between Lyramid and Cellmid will be agreed
• There will be a likely share of future IP revenue through royalties , I wish the CEO's payment came woth the same condition, Likely!
• Lyramid will be responsible for the costs of research and development Not the CEO's fat Cheque
• Lyramid will be responsible for the costs of patents
2. Currently negotiating with an overseas buyer with capacity to fund research and development
• Independent third party with no relationship to Cellmid or its officers
• Terms and structure are yet to be finalised, including any payments or future royalties
• Likely to acquire 100% of the shares in Lyramid (going concern)
3. Multiple benefits for Cellmid in the short and long term
• No further funding requirement, potential payment , WHAT ABOUT THE $150K, oh yes forgot potential payment to offset.
• Share of any future upside
• No distraction from main business, That would be true if the CEO wholly left the business!

IMO and just a guess at where the funds are going.
DYOR